Preoperative Hydronephrosis: Independent Predictor for Changes in Renal Function Following Nephroureterectomy

被引:22
作者
Hoshino, Katsura
Kikuchi, Eiji [1 ]
Tanaka, Nobuyuki
Akita, Hirotaka [2 ]
Ito, Yujiro
Miyajima, Akira
Jinzaki, Masahiro [2 ]
Oya, Mototsugu
机构
[1] Keio Univ, Dept Urol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Dept Diagnost Radiol, Sch Med, Tokyo 1608582, Japan
关键词
upper tract urothelial carcinoma; hydronephrosis; age; renal function; nephroureterectomy; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; UROTHELIAL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; OUTCOMES; METAANALYSIS; EXPERIENCE; SURVIVAL; STAGE;
D O I
10.1093/jjco/hyr199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Partial or complete urinary obstruction caused by a tumor itself may affect renal function and the eligibility for perioperative cisplatin-based chemotherapy in patients with upper tract urothelial carcinoma. We investigated whether the status of preoperative hydronephrosis provides additional predictive information concerning changes in perioperative renal function. A total of 155 patients who underwent nephroureterectomy for upper tract urothelial carcinoma from 1997 to 2010 were identified. The association between preoperative parameters including the grade of hydronephrosis and perioperative renal function was analyzed. Hydronephrosis was observed in 104 patients. The grade of hydronephrosis was 1, 2, 3 and 4 in 6 (3.9), 25 (16.1), 42 (27.1) and 31 (20.0) cases. Using a defined cut-off creatinine clearance value of epsilon 50 ml/min indicating eligibility for cisplatin-based chemotherapy, only 94 patients (60.6) were eligible in the neoadjuvant setting. Of these 94 patients, 30 (31.9) were judged to be ineligible in the adjuvant setting. Multivariate analysis demonstrated that patient age epsilon 70 years [P 0.001, hazard ratio (HR) 27.9] and the absence of a higher grade hydronephrosis (P 0.013, HR 7.40) were independent risk factors for predicting patients ineligible to receive adjuvant cisplatin-based chemotherapy. The proportion of patients ineligible to receive cisplatin-based chemotherapy changed from 40.9 to 88.6 following nephroureterectomy in patients aged epsilon 70 years and those with no or a lower grade hydronephrosis. The status of hydronephrosis is an independent predictor of eligibility to receive adjuvant cisplatin-based chemotherapy. The information on preoperative hydronephrosis and patient age may assist in part of the decision-making when considering neoadjuvant cisplatin-based chemotherapy.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 27 条
[1]   Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data [J].
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Grossman, HB ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martinez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Torti, FM ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :202-206
[2]  
Abol-Enein H, 2003, LANCET, V361, P1927
[3]  
[Anonymous], 2005, EUR UROL, V48, pdiscussion
[4]   Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma [J].
Bolenz, Christian ;
Fernandez, Mario I. ;
Trojan, Lutz ;
Herrmann, Edwin ;
Becker, Andreas ;
Weiss, Christel ;
Alken, Peter ;
Stroebel, Philipp ;
Michel, Maurice Stephan .
UROLOGY, 2008, 72 (02) :364-369
[5]   Ability of clinical grade to predict final Pathologic stage in upper urinary tract transitional cell carcinoma: Implications for therapy [J].
Brown, Gordon A. ;
Matin, Surena F. ;
Busby, J. Erik ;
Dinney, Colin P. N. ;
Grossman, H. Barton ;
Pettaway, Curtis A. ;
Munsell, Mark F. ;
Kamat, Ashish M. .
UROLOGY, 2007, 70 (02) :252-256
[6]   Transitional cell carcinoma of the upper urinary tract: Spectrum of imaging findings [J].
Browne, RFJ ;
Meehan, CP ;
Colville, J ;
Power, R ;
Torreggiani, WC .
RADIOGRAPHICS, 2005, 25 (06) :1609-1627
[7]   TUMORS OF THE UPPER URINARY-TRACT - 10 YEARS OF EXPERIENCE [J].
CHARBIT, L ;
GENDREAU, MC ;
MEE, S ;
CUKIER, J .
JOURNAL OF UROLOGY, 1991, 146 (05) :1243-1246
[8]   Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder [J].
Dash, Atreya ;
Galsky, Matthew D. ;
Vickers, Andrew J. ;
Serio, Angel M. ;
Koppie, Theresa M. ;
Dalbagni, Guido ;
Bochner, Bernard H. .
CANCER, 2006, 107 (03) :506-513
[9]   The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center [J].
Favaretto, Ricardo L. ;
Shariat, Shahrokh F. ;
Chade, Daher C. ;
Godoy, Guilherme ;
Adamy, Ari ;
Kaag, Matthew ;
Bochner, Bernard H. ;
Coleman, Jonathan ;
Dalbagni, Guido .
EUROPEAN UROLOGY, 2010, 58 (04) :574-580
[10]   Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer [J].
Grossman, HB ;
Natale, RB ;
Tangen, CM ;
Speights, VO ;
Vogelzang, NJ ;
Trump, DL ;
White, RWD ;
Sarosdy, MF ;
Wood, DP ;
Raghavan, D ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :859-866